Articles October 21, 2021 Scalable AAV Production Process for Gene Therapy Viral vectors are often used for gene transfer of specific tissue- or cell-type modifications. admin-element
ArticlesRegulatory July 29, 2021 The Role of CDMOs in Cell and Gene Therapy Process Development An experienced contract development and manufacturing organization (CDMO) can ease scaling and tech... admin-element
ArticlesDownstreamUpstream July 30, 2020 Lentiviral Vector Upstream Process in Single-use Bioreactors Lentiviruses exhibit many desirable properties as gene transfer vehicles, such as high transduction... admin-element
Articles July 2, 2020 Step Up to GMP Manufacturing or Outsource to a CDMO: Considerations and Tips Whether you are developing a new monoclonal antibody (mAb), cell therapy, gene therapy, or... admin-element
Articles March 12, 2020 Getting Ahead of the Game in Cell and Gene Therapy Successes in the clinic have placed many cell and gene therapies on an accelerated route… admin-element
ArticlesDownstream February 13, 2020 Purification of Plasmid DNA Plasmid DNA is the building block of advanced therapies. As these therapies take off, so… admin-element
ArticlesDownstreamUpstream January 30, 2020 Mapping a Route for Cell and Gene Therapy Process Development The regenerative medicine field is still quite young, and companies developing commercial processes... admin-element
ArticlesDownstreamRegulatoryUpstream July 18, 2019 Design Considerations for a Commercial Cell and Gene Therapy Facility The commercialization of cell and gene therapies has become a reality, prompting deeper... admin-element